Intellia Therapeutics Inc (NTLA)
ETFs that hold Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Inc is held by 11 ETFs tracked in our database. The largest position is held by ARKK (2.15%). The remaining funds hold it at 1.90% or less. The largest holders are mostly sector and small-cap funds.
ETFs holding Intellia Therapeutics Inc (NTLA) in our database, ranked by portfolio weight.
Which ETFs hold Intellia Therapeutics Inc (NTLA)?
The ETFs with the largest positions in Intellia Therapeutics Inc (NTLA) are: ARK Innovation ETF (ARKK, 2.15%); ARK Genomic Revolution ETF (ARKG, 1.90%); SPDR S&P Biotech ETF (XBI, 0.56%); iShares Biotechnology ETF (IBB, 0.11%); iShares Russell 2000 Value ETF (IWN, 0.10%). The full list, ranked by weight, is in the table.
How many ETFs hold Intellia Therapeutics Inc (NTLA)?
Intellia Therapeutics Inc (NTLA) is held by 11 ETFs tracked in our database. The largest position is in ARKK, where it makes up 2.15% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. ARKK holds Intellia Therapeutics Inc (NTLA) at 2.15%, and the simple average weight across the 11 funds is 0.45%.